Paclitaxel Protein-bound Particles For Injectable Suspension (albumin-bound) Injection, Powder, Lyophilized, For Suspension
Product Images NDC 72603-408

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Paclitaxel Protein-bound Particles For Injectable Suspension (albumin-bound) (NDC 72603-408). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (100 mg Carton)

Packaging label for Paclitaxel protein-bound particles for injectable suspension (albumin-bound) 100 mg per vial by NorthStar Rx LLC. The label displays dosage form as lyophilized powder for suspension, intended for intravenous use. It includes instructions for reconstitution with 0.9% sodium chloride injection and storage guidelines. The label also highlights that the product contains approximately 90 mg human albumin and is sterile, nonpyrogenic, and preservative-free. Product manufactured in Italy with labeler details and barcode shown.*

FDA Label Image

Figure 1 (Paclitaxel Figure 1)

A Kaplan-Meier survival curve comparing the proportion of patient survival over time (months) between two treatment groups: Paclitaxel protein-bound particles for injectable suspension (albumin-bound) plus Gemcitabine (solid line) and Gemcitabine alone (dashed line). The graph includes patient counts at risk for each group at various time points below the x-axis.*

FDA Label Image

Preparation Vial (Paclitaxel Prep Vial)

An instructional illustration showing a vial being inverted and connected to an intravenous (IV) drip set, demonstrating preparation for intravenous administration of a lyophilized powder injectable suspension.*

FDA Label Image

Structural Formula For Paclitaxel (Paclitaxel Structure)

Chemical structure of paclitaxel, the active ingredient in Paclitaxel protein-bound particles for injectable suspension (albumin-bound). The diagram shows the molecular arrangement of paclitaxel with characteristic ring systems and functional groups.*

FDA Label Image

Principal Display Panel (100 mg Vial)

Label for Paclitaxel Protein-Bound Particles for Injectable Suspension (albumin-bound) 100 mg per vial. The injectable powder is for intravenous use only and supplied as a single-dose vial. The label includes warnings about product substitution and storage instructions. Manufactured by Northstar Rx LLC, Memphis, TN.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.